6.61 USD
▼-0.25-3.64%
盘后 7.40 0.00%
2026-09-15
市值
$183.00M
市盈率
—
EPS
-2.59
股息率
—
52 周区间
3.53 – 9.62
成交量
314.60K
Beta
1.25
目标价
29.40
52W 低 3.5352W 高 9.62
价格走势
公司简介
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B ...